Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing 76 - 100 of 310
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • ibritumomab tiuxetan
  • BEAM chemotherapy and autologous stem-cell transplantation
  • Scottsdale, Arizona
  • +8 more
Aug 13, 2020

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

Terminated
  • Chronic Myelogenous Leukemia
  • +7 more
  • CD3/CD28 Activated T cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 12, 2020

Non-Hodgkin's Lymphoma Trial in Royal Oak, Minneapolis, Rochester (LY317615)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Royal Oak, Michigan
  • +2 more
Jul 20, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Advanced Cancer, Metastatic Cancer, Biliary Tract Carcinoma Trial in Chiba, Tokyo (Merestinib, Cisplatin, Gemcitabine)

Completed
  • Advanced Cancer
  • +6 more
  • Chiba, Japan
  • +1 more
May 18, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (GCSF, meloxicam, Placebo)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
May 15, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Idasanutlin, Obinutuzumab, Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Phoenix, Arizona
  • +23 more
Apr 29, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

Terminated
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 12, 2020

Non-Hodgkin's Lymphoma Trial in Durham (Bendamustine + Rituximab + Pixantrone, Pegfilgrastim)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Durham, North Carolina
    Duke University Medical Center
Mar 2, 2020

Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Hangzhou (CT-RD06)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
  • CT-RD06
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Feb 19, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Russian Federation, United States (SB-743921)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
  • Hackensack, New Jersey
  • +7 more
Jan 9, 2020

Non-Hodgkin's Lymphoma Trial in Germany (standard GVHD prophylaxis, rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • Heidelberg, Baden-Würtenberg, Germany
  • +5 more
Jan 9, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma Trial in San Francisco, Leeds (Vincristine Sulfate

Completed
  • Non-Hodgkin's Lymphoma
  • +2 more
  • Vincristine Sulfate Liposome Injection plus rituximab
  • San Francisco, California
  • +1 more
Dec 31, 2019

Non-Hodgkin's Lymphoma Trial in Tucson, Lebanon, Hackensack (ABT-199)

Completed
  • Non-Hodgkin's Lymphoma
  • Tucson, Arizona
  • +2 more
Dec 18, 2019

Non-Hodgkin's Lymphoma Trial in Madison (Ibritumomab Tiuxetan (Zevalin) + Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Ibritumomab Tiuxetan (Zevalin) + Rituximab
  • Madison, Wisconsin
    University Of Wisconsin
Dec 11, 2019

MDS, AML, Solid Tumors Trial in United States (azacitidine)

Completed
Has Results
  • MDS
  • +5 more
  • Berkeley, California
  • +10 more
Nov 6, 2019

Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • San Diego, California
  • +91 more
Nov 6, 2019

Hodgkin's Lymphoma, Leukemia, Lymphoid Leukemia Trial in Madison (Behavioral techniques)

Completed
  • Hodgkin's Lymphoma
  • +6 more
  • Behavioral techniques
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 14, 2019

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Ublituximab + TGR-1202, Ublituximab + TGR-1202 +

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Ublituximab + TGR-1202
  • +2 more
  • Huntsville, Alabama
  • +5 more
Nov 4, 2019

Non-Hodgkin's Lymphoma, Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma, Chronic Lymphoblastic Leukemia Trial in Tianjin

Unknown status
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Autologous γδT cells
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 24, 2019

Non-Hodgkin's Lymphoma Trial in Miami, Chicago, Philadelphia (Rituximab, bortezomib)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Miami, Florida
  • +3 more
Aug 26, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma Trial in Minneapolis (852A)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Aug 21, 2019